Top 50 Medical Startup Investors in Denmark (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
BioInnovation Institute
VC Fund
|
13 | Denmark, Germany, Switzerland | Convertible Note, Pre-Seed, Debt Financing | Biotechnology, Medical, Health Care | $516k–$5.2M |
|
Novo Holdings
VC Fund
|
12 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $8M–$125M |
|
Export and Investment Fund
VC Fund
|
7 | Denmark, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Health Care | $395k–$84M |
|
Vaekstfonden
VC Fund
|
6 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $440k–$4.6M |
|
Forbion Capital Partners
VC Fund
|
3 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $12M–$176M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $1k–$17M |
|
Bioqube Ventures
VC Fund
|
3 | United States, France, Norway | Seed, Series A, Series B | Biotechnology, Therapeutics, Life Science | $4M–$108M |
|
Sunstone Life Science Ventures
VC Fund
|
3 | Denmark, Sweden, Switzerland | Series B, Series A | Biotechnology, Health Care, Medical | $5.5M–$52M |
|
Seed Capital
VC Fund
|
3 | Denmark, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $515k–$17M |
|
People Ventures
VC Fund
|
2 | Denmark, Sweden, United States | Seed, Pre-Seed, Series A | Software, Health Care, Internet of Things | $1.1M–$21M |
|
Innovation Fund Denmark
VC Fund
|
2 | Denmark, United States | Grant, Pre-Seed, Seed | Software, Biotechnology, SaaS | $22k–$1.6M |
|
PSV
VC Fund
|
2 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $88k–$4.6M |
|
Wellcome Trust
VC Fund
|
2 | United States, United Kingdom, France | Grant, Series C | Biotechnology, Health Care, Medical | $1.3M–$127M |
|
VentureFriends
VC Fund
|
2 | Greece, United Kingdom, United States | Seed, Series A, Pre-Seed | FinTech, Software, E-Commerce | $105k–$25M |
|
CAPNOVA
VC Fund
|
2 | Denmark, United States, India | Seed, Pre-Seed | Software, Information Technology, B2B | $147k–$2.4M |
|
Inovo.vc
VC Fund
|
1 | Poland, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, SaaS | |
|
Teknoinvest
VC Fund
|
1 | Sweden, Norway, United States | Series B, Series A | Biotechnology, Health Care, Medical | |
|
North Ventures
VC Fund
|
1 | Denmark | Series A | Financial Services | |
|
p53
VC Fund
|
1 | Norway, Denmark | Series A | Biotechnology, Medical, Life Science | $31M–$82M |
|
VF Venture
VC Fund
|
1 | Denmark, United Kingdom, Iceland | Seed, Series A | Software, SaaS, Biotechnology | $1.2M–$22M |
|
Jørleif Joensen
Angel
|
1 | Denmark | Pre-Seed | Medical, Health Care | |
|
Innovestor
VC Fund
|
1 | Finland, Denmark, Sweden | Seed, Pre-Seed | Software, Health Care, Information Technology | $163k–$4.1M |
|
M Ventures
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Eli Lilly
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Medical | |
|
Biofund
VC Fund
|
1 | Canada, Denmark, Russian Federation | Seed | Genetics, Medical, Health Care | |
|
Sagitta Ventures
VC Fund
|
1 | Sweden | Series B | Aerospace | |
|
Cormorant Asset Management
VC Fund
|
1 | United States, China, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Industrifonden
VC Fund
|
1 | Sweden, United States, Denmark | Series A, Seed | Software, Biotechnology, Information Technology | $1.1M–$21M |
|
Bossa Invest
VC Fund
|
1 | Brazil, United States, Mexico | Seed, Pre-Seed | Software, Information Technology, Financial Services | $29k–$5M |
|
DigitalDx Ventures
VC Fund
|
1 | United States, Canada, Denmark | Series A, Seed | Biotechnology, Health Care, Medical | $3.5M–$18M |
|
Danske Bank
VC Fund
|
1 | Sweden, Denmark, Finland | Post-IPO Debt, Debt Financing | Manufacturing, Energy, Biotechnology | $3.3M–$3B |
|
BankInvest Biomedical Venture
VC Fund
|
1 | Denmark, United Kingdom, France | Series B, Series C | Biotechnology, Health Care, Medical | $6.1M–$14M |
|
Crista Galli Ventures
VC Fund
|
1 | United Kingdom, United States, Sweden | Seed, Pre-Seed, Series A | Health Care, Medical, Wellness | $655k–$14M |
|
EISMEA
VC Fund
|
1 | Spain, Switzerland, United Kingdom | Grant, Seed | Biotechnology, Software, Health Care | $55k–$2.7M |
|
Polaris Partners
VC Fund
|
1 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$112M |
|
LS Polaris Innovation Fund
VC Fund
|
1 | United States, Denmark | Series A, Series B | Biotechnology, Medical, Biopharma | $22M–$83M |
|
Dansk Erhvervsinvestering
VC Fund
|
1 | Denmark | Medical, Health Care, Biotechnology | ||
|
Inkef
VC Fund
|
1 | The Netherlands, United States, Germany | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2.2M–$88M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $6M–$102M |
|
CBC Investment Group
VC Fund
|
1 | Sweden, Denmark, Germany | Seed, Series B | Software, Biotechnology, SaaS | |
|
Novo Ventures
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $8.5M–$143M |
|
Penny Schiffer
Angel
|
1 | Switzerland, Germany, United Kingdom | Seed, Series A | Medical, Health Care, Finance | $544k–$9.3M |
|
European Investment Bank
VC Fund
|
1 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $7.7M–$658M |
|
Sound Bioventures
VC Fund
|
1 | United States, United Kingdom, France | Series A, Seed | Biotechnology, Medical, Therapeutics | $18M–$83M |
|
VIB
VC Fund
|
1 | Belgium, Brazil, Denmark | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$84M |
|
Roche Venture Fund
VC Fund
|
1 | United States, United Kingdom, Spain | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$105M |
|
Morten Strunge
Angel
|
1 | Denmark, United States | Seed, Pre-Seed | Fashion, E-Commerce, Beauty | |
|
Bhavik Bajaj
Angel
|
1 | United States, Switzerland, United Kingdom | Pre-Seed, Seed, Angel | Information Technology, Software, FinTech | $15k–$3M |
|
V-Bio Ventures
VC Fund
|
1 | Belgium, France, United States | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$88M |
|
Droia Ventures
VC Fund
|
1 | United States, Belgium, The Netherlands | Series A, Series B, Series C | Biotechnology, Medical, Health Care | $13M–$125M |
| Access all 127 investors in Denmark Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Convertible Note, Pre-Seed, Debt Financing
- Geography: Denmark, Germany, Switzerland
Investor stats
- Total investments: 72
- Round size: Pre-Seed $516k–$5.2M; Debt Financing $549k–$1.4M; Convertible Note $549k–$1.5M
- Lead/follow: 90% lead, 10% follow
Portfolio highlights
- Zeta Diagnostics — First-in-class hardware-and-software-as-a-service diagnostics for the 400M suffering from middle ear problems
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 313
- Round size: Series A $8M–$100M; Series B $12M–$125M; Series C $30M–$115M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Hillstar Bio — Hillstar Bio is pioneering precision immunotherapies that target and deplete pathogenic immune cells, aiming to reset the immune system and transform treatment for autoimmune diseases.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Bolt Biotherapeutics — Bolt is leveraging the immune system for a better way to treat cancer. Our approach works with a person's body, not against it.
Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 101
- Round size: Seed $395k–$11M; Series A $3.8M–$84M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Akson Robotics — Akson Robotics is a developer of AI and robotics-based products that focus on greener and efficient agriculture through precision farming.
- Aquark Technologies — Aquark Technologies develops atom systems to develop quantum applications, including atomic clocks, sensors, and navigation systems. Aquark develops a technique to miniaturize cold atom systems using unique laser geometry that is based on more than 10 years of proprietary research at the University of Southampton.
- Coalescent Mobile Robotics — Coalescent Mobile Robotics is a robotics company developing mobile robots to automate transportation processes in the mutilple industries.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Seed $810k–$4.6M; Pre-Seed $440k–$1.2M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Captego — Unique, high-speed field data capture. Empower your inspectors & surveyors with our unique collection app. Benefit from high quality data to automate reports and data insights.
- LastSwab — LastSwab launched May 2019 through the crowdfunding platform Kickstarter. At $16 a swab, LastSwab is meant to last at least 1,000 uses and is the easy-to-clean, reusable alternative to the abundant waste caused by single-use swabs around the globe. The tip of the swab is made from medical silicone and nylon and comes in a biodegradable case made ofa corn-based material. LastSwab can be easily cleaned using soap and water and is also dishwasher safe. It comes in a standard swab for cleaning and a pointed swab for makeup application. Be the change and #SwabYourHabits.
- Donkey Republic — Donkey Republic is leading bike share service in Europe with footprint in more than 10 key cities in Europe. We operate our locations with partners, and use custom-branded bikes. Our software backbone is developed by us with unique features that ensure we respect public space with our hub-centric service model. At the same time, we maximizepredictability of bike availability and convenience. We pride ourselves in service innovation.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 171
- Round size: Series A $14M–$176M; Series B $12M–$155M; Series C $12M–$113M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
- Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
- Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 45
- Round size: Seed $1.6M–$4.7M; Pre-Seed $1k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 51% lead, 49% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States, France, Norway
Investor stats
- Total investments: 18
- Round size: Seed $5.7M–$21M; Series A $4M–$76M; Series B $23M–$108M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- Commit Biologics — Add a description for facebook
- Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 55
- Round size: Series A $5.5M–$43M; Series B $9.6M–$52M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $94M in 2019
Portfolio highlights
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 180
- Round size: Seed $515k–$4.9M; Series A $3.5M–$17M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely still investing — raised $73M in 2021
Portfolio highlights
- Cardlay — Build your own white-label card and expense management solution with Cardlay. Our platform helps banks, fleets, and tech partners launch modern spend management solutions fast.
- Flatpay — Flatpay's fair, flat-rate pricing simplifies payments & cuts costs. Benefit from our comprehensive solution & superior customer service. Join us now!
- Templafy — Templafy automates documents to remove risk and increase efficiency for over 800 organizations around the world.
Backing founders with people, money and presence | People Ventures
Show more...Investment focus
- Industry: Software, Health Care, Internet of Things
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 29
- Round size: Seed $1.1M–$19M; Pre-Seed $1.5M–$1.6M; Series A $6.3M–$21M
- Lead/follow: 62% lead, 38% follow
Portfolio highlights
- Opally — The aim of Opally is to assist hospitality professionals in spending more time crafting exceptional guest experiences and less time on emails.
- Hosted·AI — Hosted·AI is a software company that offers GPUaaS orchestration, AI tools, and cloud infrastructure solutions.
- Pandektes — Legal Research, redefined.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Pre-Seed, Seed
- Geography: Denmark, United States
Investor stats
- Total investments: 87
- Round size: Seed $66k–$1.3M; Grant $22k–$1.1M; Pre-Seed $64k–$1.6M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Prezio — Prezio is an electricity tariff data API for Europe. We aggregate, structure, and serve real-time and historical electricity pricing data - spot prices, retail tariffs, and grid fees - so energy applications don't have to build and maintain that data infrastructure themselves. Typical customers are developers and product teams building EVsmart charging, heat pump control, home batteries, and solar optimization tools - anything that needs to know what electricity actually costs, right now or over time, across European markets.
- ENZIDIA — We crack the fundamental bottlenecks of enzyme engineering with unprecedented screening and data collection capacity
- Cacto Health — Cacto Health is the Developer of a medical device system designed for monitoring lymphedema in breast cancer patients.
PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 136
- Round size: Seed $500k–$4.6M; Pre-Seed $88k–$2.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $42M in 2020
Portfolio highlights
- Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
- Thiax — ThiaX maps the strain and crystallinity in polymer and composite materials using cutting-edge X-ray diffraction (XRD) technology.
- Enerin — Enerin reduces energy consumption and costs through our know-how within energy technology and operation of heating and cooling systems, including industrial heat pumps through our products Thermonitor, HoegTemp, WaveClean, Feedwater systems and Niprox water treatment.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 115
- Round size: Grant $1.3M–$8M; Series C $10M–$127M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $319M in 2018
Portfolio highlights
- Cultivarium — We develop molecular, hardware and software tools to accelerate the adoption of microbes for beneficial biotechnologies.
- Lario Therapeutics — Lario Therapeutics is a biopharmaceutical firm that develops precision therapeutics for epilepsy and neurological disorders.
- Ineffable Intelligence — Ineffable Intelligence develops machine learning systems that learn through interaction and experience. The company works on reinforcement learning approaches that allow models to improve by trial and error rather than relying on large human-generated datasets. Its core work centers on building a “superlearner,” a system designed to generateknowledge and skills by engaging with simulated or real environments.The organization develops algorithms and computational frameworks that support autonomous learning, experimentation, and decision-making processes. Its efforts involve designing AI models that can adapt, refine behavior, and solve complex problems through continuous feedback loops. The company’s research aims to expand how AI systems acquire knowledge and apply it across different domains.
VentureFriends is a venture capital fund that invests in tech-enabled companies. VentureFriends (VF) is a venture capital fund specialising in seed stage startups. VF seeks to invest in tech-enabled B2C and B2B startups that can develop a sustainable moat over time and have a sweet spot for PropTech, FinTech, Marketplaces, and SaaS. The fundtypically invests between €0.3M - €2.5M and can follow on up to a total of €5 - 10M. VentureFriends invests predominantly in Europe and is founded by ex-entrepreneurs and angel investors, thus having an entrepreneurial and founder-friendly philosophy.
Show more...Investment focus
- Industry: FinTech, Software, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: Greece, United Kingdom, United States
Investor stats
- Total investments: 120
- Round size: Seed $424k–$6.7M; Pre-Seed $105k–$3.4M; Series A $2.7M–$25M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $110M in 2021
Portfolio highlights
- BibeCoffee — BibeCoffee is an IoT real-time monitoring solution that transforms every professional coffee machine to a smart connected terminal minimizing revenue Loss and safeguarding brand quality image
- Spotawheel — Spotawheel is a trusted high-tech used cars B2C platform that redesigns the whole buy-sell process from scratch, ensuring value, transparency and customer satisfaction at the highest levels throughout.
- Cube AI — Cube AI provides software that applies machine learning to business workflows and data. The platform enables creation of AI assistants, connections to internal data sources, and task automation through APIs and integrations. Capabilities include natural language processing for classification, summarization, and question answering, retrieval overdocuments and knowledge bases, and analytics that surface insights from structured and unstructured data. Solutions cover use cases such as customer support, sales enablement, lead routing, and document processing, helping teams reduce manual steps and standardize processes. Tooling includes SDKs, dashboards, and monitoring to deploy, observe, and refine models in production.
They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.
Show more...Investment focus
- Industry: Software, Information Technology, B2B
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, India
Investor stats
- Total investments: 24
- Round size: Seed $147k–$2.4M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Ulobby — Ulobby is an automated tool for stakeholder management and political monitoring
- Mechanic Miner — Mechanic Miner is a 2D construction/survival game with mechanical steam-powered machines. You are stranded on a strange and forbidding planet, where survival is made difficult by hostile animals and plant life. From your home world you did bring a multitool, which is able to craft any kind of machine part - provided the requisite rawmaterials can be found. Relying solely on the technology you brought, you set out to explore a whole world. You can progress through the game by acquiring new types of steam-powered technology elements, that are necessary to delve deeper into the diverse biomes of the planet, and perhaps, ultimately, discover the means to escape. You can construct any kind of machine of your own design - and any kind of machine can be simulated by the game's physics engine - and of course, designs can be shared with your friends.
- ResoTher Pharma — ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on developing peptide-based drugs derived from the endogenous immunomodulator Annexin 1A as resolution therapy for diseases where neutrophil-driven inflammation plays a key pathological role.
VC for the most ambitious founders in CEE
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Poland, United States, United Kingdom
Investor stats
- Total investments: 77
- Lead/follow: no public data
Portfolio highlights
- Jutro Medical — Jutro Medical offers a combination of online and offline primary care — pairing mobile first telemedicine with physical clinic
- Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
- sintra.ai — Build, grow, and scale your business with a team that never sleeps.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
North Ventures is a venture capital firm investing in technology-driven companies from Seed to Series A in Denmark and across the Nordics.
Show more...Investment focus
- Industry: Financial Services
- Stage:Series A
- Geography: Denmark
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Monthio — Embrace the future of lending with Open Banking for credit decisioning. Streamline loan applications, increase accessibility, and deliver exceptional customer service.
- Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Series A
- Geography: Norway, Denmark
Investor stats
- Total investments: 2
- Round size: Series A $31M–$82M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Calluna Pharma — Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: Denmark, United Kingdom, Iceland
Investor stats
- Total investments: 29
- Round size: Seed $1.2M–$9.1M; Series A $5.6M–$22M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Tame — ABOUT With Tame you can fully customise your virtual events, and make them fun, engaging & exciting to attend.- Apply your branding: Customise your virtual event completely - Personalised Welcome: Personal welcome message when attendees enter - Multiple stages: Broadcast content across multiple stages. - Live streaming: Stream live via anybroadcasting software - Pre-recorded videos: Broadcast pre-recorded videos as if it was live - Breakout sessions: Enable public or private breakout sessions. - Virtual Sponsor booths: Allow attendees to engage with sponsors live. - Customise Chat: Allow for 1:1 chat, group chat or session chat. - 1:1 Video Meetings: Empower social networking virtually.OUR COMPANY We are an experience-centric company, and we believe in the power of great experiences. Our international group of dreamers, creators and rule-breakers passionate about merging design and technology together, enables us to transform that into one truly amazing event platform.OUR PEOPLE The team behind Tame has an aggregated decades long experience of creating events and building products that solve real problems for real people. So, what got us here? Our ambition to change a broken event industry through innovation, customer obsession and a relentless focus on the great experience.
- Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jørleif Joensen
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Pre-Seed
- Geography: Denmark
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sumondo — A medically approved digital healthcare solution for your stress. Sumondo app provides guided meditation, breathing exercises, relaxing music, accurate, trusted & validated stress measurement.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 74
- Round size: Seed $507k–$4.1M; Pre-Seed $163k–$2M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 163
- Round size: Seed $2.4M–$21M; Series A $5.2M–$45M; Series B $15M–$100M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- CellFE — We transform the way cell therapies are manufactured to enable affordable advanced treatments for all.
- UNISERS — Developing solutions for Universal Contamination Analysis. Working with cutting edge technologies to revolutionize contamination control.
- Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 111
- Lead/follow: no public data
Portfolio highlights
- Excelsior Sciences — Rebuilding the World, From the Bottom Up
- Syndeio Biosciences — Syndeio Biosciences is a clinical-stage biotechnology company focused on developing therapies to restore and enhance synaptic health in central nervous system (CNS) disorders.
- Affinia Therapeutics — Affinia Therapeutics is expanding what's possible in adeno-associated virus (AAV) gene therapy today and bringing transformative medicines for people.
BIOFUND SpA, established by Fondazione Monte dei Paschi, Bank Monte dei Paschi , Finanziaria Senese di Sviluppo e Fidi Toscana, provides the initial seed capital for companies located in the incubator of Toscana Life Sciences in Siena.
Show more...Investment focus
- Industry: Genetics, Medical, Health Care
- Stage:Seed
- Geography: Canada, Denmark, Russian Federation
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- RTM Diagnostika — Diagnostic microwave radio RTM-01-RESThe temperature and rate of growth of malignant tumorsCancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data werefirst obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous.The internal temperature - measure of angiogenesisIn 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.
- Genizon BioSciences — Since 2005, we have helped thousands of people get the perfect domain name.
Sagitta Ventures invests in early-stage companies in the Nordics and provides long-term capital backing for well-managed businesses that are seeking minority investors without a defined exit horizon.
Show more...Investment focus
- Industry: Aerospace
- Stage:Series B
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Cerebriu — Cerebriu is a health tech company developing machine learning in medical imaging that improves workflow efficiency and quality in radiology.Its software solution Cerebriu Apollo achieves the company's aim by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of thediagnostic process. The company covers findings of the brain, starting with brain MRI, including stroke, bleeds, and tumors, following MS, dementia, and TBI in brain CT.
- Ward 24/7 — Ward 24/7 develops a wireless assessment of respiratory and circulatory distress to monitor and observe high-risk patients. Its intelligent clinical support system monitors oxygen saturation, respiratory rate, cardiac function, and other parameters for patients suspected of circulatory and respiratory distress. With a series of wirelesssensors that transmit data to a server and artificial intelligence that monitors the incoming data and alerts staff to potentially critical situations, it helps healthcare providers to have the proper equipment for diagnosis.The company was founded in 2016 and is headquartered in Copenhagen, Denmark.
- Heart Aerospace — Heart’s mission is to create the fastest, most affordable and sustainable transportation for regional travel to every corner of the world. Their first aircraft is the ES-19, a nineteen-passenger airliner with an operating range of 400 km. Heart's goal is to have the aircraft certified for commercial operation by 2026.
Cormorant Asset Management is an employee-owned hedge fund sponsor that provides its services to pooled investment vehicles. The firm also focuses on both public and private market innovative companies in the biotechnology and life sciences marketplace.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Switzerland
Investor stats
- Total investments: 157
- Lead/follow: no public data
Portfolio highlights
- Numab — Numab Therapeutics AG
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
- Edgewise Therapeutics — See how we bring our unique expertise and singular focus on muscle science to develop novel therapeutics for serious skeletal and cardiac muscle diseases.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 174
- Round size: Seed $1.1M–$6.3M; Series A $3.3M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
- Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations
- Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Aprenda a Investir em Startups
Show more...Investment focus
- Industry: Software, Information Technology, Financial Services
- Stage:Seed, Pre-Seed
- Geography: Brazil, United States, Mexico
Investor stats
- Total investments: 470
- Round size: Seed $181k–$5M; Pre-Seed $29k–$600k
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $362k in 2019
Portfolio highlights
- Guapeco — Guapeco provides customized pet insurance services that helps pet parents take care of well-being of their pets through a health plan
- You.com — you.com is a search engine that helps users find what they're looking for by prioritizing real results. It aims to take on Google and other search engines dependent on advertising. It offers privacy controls to let users customize their browsing experience. It raises the bar on privacy, offering a zero trace incognito mode. It never tracksusers on the internet.You.com was developed by former Salesforce chief scientist Richard Socher.
- Elemeno Health — Elemeno Health is an intuitive, cloud-based app, customized to specific needs of your hospital or unit. Streamline training and communication, drive best practices, and empower your staff with just-in-time access to critical information.
DigitalDx Ventures is a Silicon Valley Venture firm uniquely positioned to find, support, mentor and grow the outliers in digital healthcare. DDX invests in early stage companies who effectively and efficiently harness the power of artificial intelligence and big data to profoundly impact outcomes in both diagnostics and therapeutics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed
- Geography: United States, Canada, Denmark
Investor stats
- Total investments: 7
- Round size: Series A $3.5M–$18M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $9.7M in 2019
Portfolio highlights
- OxCan — Enabling curative cancer treatment through early detection
- GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
- Optina Diagnostics — Optina Diagnostics develops technology for the early detection of disease through the eye.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Danske Bank is a Nordic universal bank offering a full range of banking services. It was founded 5 October 1871 as Den Danske Landmandsbank, Hypothek- og Vexelbank i Kjøbenhavn (The Danish Farmers' Bank, Mortgage and Exchange Bank of Copenhagen). It is headquartered in Copenhagen, Denmark and is one of the major retail banks in the northernEuropean region with over 5 million retail customers.Danske Bank was number 454 on the Fortune Global 500 list for 2011.
Show more...Investment focus
- Industry: Manufacturing, Energy, Biotechnology
- Stage:Post-IPO Debt, Debt Financing
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 31
- Round size: Post-IPO Debt $24M–$3B; Debt Financing $3.3M–$1.6B
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Fortum — By providing our customers and the Nordic energy system with a supply of reliable energy, we aim to power a world where people, businesses, and nature thrive together. With respect for the environment, decades of expertise and smart solutions, we strive to meet our customers' needs.
- Sitowise — Sitowise is an expert company of over 1,200 personnel that provides its customers the full range of built environment services from planning to expert and digital services. Sitowise is the largest Finnish-owned planning and consulting agency in the construction industry, the leading expert in urban diversified projects, and a pioneer indata-driven management and data modelling.
- Triangle Progression To Employment — Triangle Progression To Employment is an organization that provides supported living and housing services.
BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C
- Geography: Denmark, United Kingdom, France
Investor stats
- Total investments: 9
- Round size: Series B $8M–$8.8M; Series C $6.1M–$14M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
- Nereus Pharmaceuticals — Nereus Pharmaceuticals, Inc. engages in the discovery and development of therapeutics for the treatment of oncology, infectious diseases, and inflammation. The company uses its marine microbiology technologies for the discovery and development of drug candidates. Its oncology drug candidates include NPI-2358, a tumor vascular disrupting agent forthe treatment of solid tumors; and NPI-0052, a proteasome inhibitor for the treatment of solid tumors, lymphomas, and multiple myeloma. The company was founded in 1998 and is based in San Diego, California.
- Resistentia Pharmaceuticals — Resistentia Pharmaceuticals, a biopharmaceutical company, develops immunotherapeutic products for allergic asthma and inflammatory disorders. It provides Immunoglobulin E for allergic reactions, including asthma, rhinitis, and dermatitis; and C5a for the treatment of inflammatory conditions, such as rheumatoid arthritis, asthma, and multiplesclerosis. Resistentia Pharmaceuticals AB was founded in 1998 and is based in Uppsala, Sweden.
Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 36
- Round size: Seed $960k–$8.5M; Pre-Seed $655k–$2.5M; Series A $5.2M–$14M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds Radiology — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Executive Agency for SMEs
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed
- Geography: Spain, Switzerland, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $55k–$2.2M; Grant $55k–$2.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- Cyclomics — Discover Cyclomics, pioneers in precision cancer diagnostics using breakthrough consensus-sequencing paired with the Nanopore platform. Our innovative solutions enable ultra-sensitive detection of cancer mutations directly from blood samples, transforming the future of liquid biopsy. Learn more about how Cyclomics is revolutionizing early cancer detection, monitoring, and personalized treatment with cutting-edge, accessible molecular diagnostics.
- Terraplasma — As pioneers in cold plasma science, our team of scientists, engineers, and experts have played a key role in driving research and commercial development. Our groundbreaking work has brought cold plasma technology to companies, public institutions and even private households worldwide.
Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 446
- Round size: Series A $4.5M–$80M; Series B $7M–$112M; Series C $10M–$105M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $182M in 1998
Portfolio highlights
- Cohere Health — Cohere Health can help your organization improve its utilization management process. We are transforming the way patients, physicians and health plans work together.
- Thirty Madison — Thirty Madison is a human-first healthcare company, powering access to affordable specialized healthcare through brands like Keeps and Cove.
- Invivyd — Adagio is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patientsand clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with thirdparty contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.
The LS Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early stage academic research.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Series A, Series B
- Geography: United States, Denmark
Investor stats
- Total investments: 6
- Round size: Series A $22M–$83M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Glympse Bio — Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platformtechnology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
- Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
- Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Dansk Erhvervsinvestering is a company that assists individuals with investing.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Geography: Denmark
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Genmab — Genmab is an international biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Genmab's discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs. Its primary goal is to improve the lives ofpatients who are in urgent need of new treatment options.
- PremiTech — PremiTech A/S develops systems management software. It offers Performance Guard, a solution that enables IT departments to get real-time measurement of end-user application and infrastructure IT performance in software as a service model. The company also provides Performance Guard CIO Dashboard Module, which provides a view into the ITinfrastructures performance based on grouping by location and application; and Performance Guard Health Check Module that delivers reports on infrastructure components, including applications, mid-tier servers, network and PC Infrastructure for automated, out-of-the-box fast performance documentation, and issue resolution. In addition, it offers monitoring and documentation, and performance monitoring solutions. The company has strategic partnerships with HP, Computer Associates, BMC, VMWare, IBM, and Microsoft. PremiTech A/S was founded in 1999 and is headquartered in Hedehusene, Denmark. As of 2008, PremiTech A/S operates as a subsidiary of CapaSystems A/S.
SVB - Europe's biggest online shop for boating equipment and accessories! Worldwide delivery, even directly on-board!
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: The Netherlands, United States, Germany
Investor stats
- Total investments: 83
- Round size: Seed $2.8M–$21M; Series A $3.2M–$42M; Series B $2.2M–$88M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — raised $585M in 2016
Portfolio highlights
- NMD Pharma — NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.Importantly, the approach improves neuromuscular transmission in a way that ispotentially applicable to a range of clinical indications and orphan human diseases that have profound unmet medical need.
- Comet Therapeutics — DropCatch.com helps you secure expiring domain names.
- Cardior Pharmaceuticals — Pioneering the discovery and development of RNA-based therapeutics designed to prevent, repair and reverse diseases of the heart.
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 298
- Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $200M in 2023
Portfolio highlights
- protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Seed, Series B
- Geography: Sweden, Denmark, Germany
Investor stats
- Total investments: 12
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- GLX Analytix — GLX Analytix is a biomedical company that develops a new technology to identify a biomarker. The company was founded in 2019 and is based in Copenhagen, Denmark.
- Swiftly — World's first AI that applies for jobs. Say goodbye to creating CV's, searching and applying for jobs. Let Swiftly do it for you! Welcome to the new age.
- Hugel Control — HUGEL, Inc. strives to be a global company that continuously creates innovative products, promotes universal health, and improves the quality of life through state-of-the-art technology and creativity.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 79
- Round size: Series A $8.5M–$74M; Series B $14M–$75M; Series C $13M–$143M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- PanOptica — PanOptica is a biopharmaceutical company developing a topical eye drop for the treatment of eye diseases caused by abnormal or leaky blood vessels.
- Galera Therapeutics — Developing novel therapies that have the potential to reduce radiotherapy-induced toxicities and improve the anti-cancer efficacy of radiation therapy
- Reneo Pharmaceuticals — OnKure Therapeutics - Writing the Next Chapter in Precision Medicines for Patients With Cancer
Penny Schiffer - CEO & Co-founder @ Raized.ai
Show more...Investment focus
- Industry: Medical, Health Care, Finance
- Stage:Seed, Series A
- Geography: Switzerland, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $544k–$9.3M; Series A $1.2M–$7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Versameb — Versameb AG is a preclinical-stage biopharmaceutical company located in Basel, Switzerland managed by an experienced scientific and business pharmaceutical industry team. The company’s focus is the development of novel RNA-based therapeutics. Versameb’s proprietary VERSagile technology platform enables efficient development of functional mRNAmolecules for customized protein expression and modification in multiple disease areas with high unmet medical need.
- Enterprise Bot — Cost-effective Conversational AI solutions transforming customer interaction for global enterprises. Discover cutting-edge chat, email, and voice tech.
- Scientific Visual — Scientific Visual supplies quality control workstations to visualize defects in non-polished sapphire such as watch covers, ingots and wafers.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 294
- Round size: Post-IPO Debt $7.7M–$658M; Debt Financing $13M–$400M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
- Interconnect Malta — Interconnect Malta is a government organization that develops and implements energy infrastructure projects.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 8
- Round size: Series A $18M–$83M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
- Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Strategic research in on life sciences and biotechnology
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, Brazil, Denmark
Investor stats
- Total investments: 21
- Round size: Seed $3.2M–$4.6M; Series A $6.8M–$84M; Series B $4.4M–$65M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biotalys — Biotalys is an Agricultural Technology (AgTech) company that employs its proprietary Agrobody technology platform to develop crop and food protection products. The company develops a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Biotalys' unique protein-based biocontrols combinethe high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications.It was incorporated in 2013 and is based in the Biotech hub in Ghent, Belgium.
- Confo Therapeutics — Confo Therapeutics is a clinical-stage company committed to accelerating novel GPCR-directed medicines for metabolic & endocrine diseases.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
We are the corporate venture fund of Roche, a global leader in bringing medicines and in vitro diagnostics to the benefit of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 110
- Round size: Series A $6M–$59M; Series B $10M–$100M; Series C $5M–$105M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Morten Strunge is the current Co-Founder of Nexta.io. He previously worked at Storytel AB as a Board Member.
Show more...Investment focus
- Industry: Fashion, E-Commerce, Beauty
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States
Investor stats
- Total investments: 5
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- UXCam — Our AI analyzes millions of data points to give you insights in under 30 seconds. Act fast. Lead with evidence. Impress stakeholders.
- Goodiebox — Goodiebox is an online cosmetic company that provides cosmetics and beauty products. It has developed a subscription business selling cosmetics and beauty products to women in the 15-35 years old range. They give both large international brands and smaller niche brands the opportunity to market their products directly to a specific target groupthat is interested in their products.The company mission is to create relationships between the beauty and cosmetics brands and consumers. It also distributes a box of cosmetics including products of various brands to women.Goodiebox was founded in 2012 and is headquartered in Copenhagen S, Capital Region, Denmark.
- SON OF A TAILOR — Custom tailored T-Shirts with Free Remake Guarantee. We use only the highest quality materials.
Bhavik Bajaj
Show more...Investment focus
- Industry: Information Technology, Software, FinTech
- Stage:Pre-Seed, Seed, Angel
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $100k–$3M; Angel $15k–$1.6M; Pre-Seed $43k–$1.3M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Asepha — Asepha is an AI clinical decision support (CDS) tool to help healthcare professionals make faster clinical decisions.
- ORA Technologies — E-Commerce, Super App
- THIRUMALS PAPER ARIZONA PVT. LTD. — TRADING PLATFORM OF PULP , PAPER & PACKAGING
V-Bio Ventures is an independent venture capital firm specialized in building and financing young, innovative life science companies. The fund invests throughout Europe in start-up and early-stage companies with high growth potential focusing on technologies that provide transformational improvements in the biotech, pharmaceutical and agriculturalsectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Belgium, France, United States
Investor stats
- Total investments: 38
- Round size: Seed $3.2M–$50M; Series A $6.6M–$73M; Series B $20M–$88M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $129M in 2021
Portfolio highlights
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
- Corteria Pharmaceuticals — Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations, focused on the development of transformative therapies for the treatment of worsening and acute decompensated heart failure.
Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives. We invest in the most promising life science companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Series C
- Geography: United States, Belgium, The Netherlands
Investor stats
- Total investments: 37
- Round size: Series A $15M–$73M; Series B $13M–$89M; Series C $75M–$125M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $241M in 2021
Portfolio highlights
- Hillstar Bio — Hillstar Bio is pioneering precision immunotherapies that target and deplete pathogenic immune cells, aiming to reset the immune system and transform treatment for autoimmune diseases.
- Cyteir Therapeutics — Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly ownedlead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.
- Cristal Therapeutics — Cristal Therapeutics offers CliCr: a powerful copper-free click chemistry reagent that meets all demands of the life science industry.
Medical Investor funding in Denmark at a glance
Stats across 151 deals from 127 investors.
Access all 127 investors in Denmark Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 127 investors investing in Denmark Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!